Open AccessEndothelial nitric oxide synthase inhibits the development of autoimmune‐mediated vasculitis in mice
Author(s) -
Schoeb Trenton R.,
Jarmi Tambi,
Hicks M. John,
Henke Scott,
Zarjou Abolfazl,
Suzuki Hitoshi,
Kramer Philip,
Novak Jan,
Agarwal Anupam,
Bullard Daniel C.
Publication year - 2012
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/art.37683
Subject(s) - enos , vasculitis , glomerulonephritis , nitric oxide , pathogenesis , lesion , medicine , nitric oxide synthase , immune complex , endocrinology , nitric oxide synthase type iii , inflammation , immunology , immune system , kidney , pathology , disease
Objective Many different genes or mediators have been implicated in promoting the development of vasculitis, although little is known regarding the mechanisms that normally act to suppress lesion formation. Endothelial nitric oxide synthase (eNOS) has been shown to inhibit vascular inflammation in many different model systems, but its roles in the pathogenesis of vasculitis have not been elucidated. This study was undertaken to determine the functions of eNOS in the initiation and progression of vasculitic lesion formation. Methods MRL/MpJ‐ Fas lpr mice lacking the gene for eNOS ( Nos3 −/− ) were generated and comprehensively evaluated and compared to controls with regard to the development of autoimmune disease, including vasculitic lesion formation and glomerulonephritis. Results Nos3 −/− MRL/MpJ‐ Fas lpr mice exhibited accelerated onset and increased incidence of renal vasculitis compared to Nos3 +/+ controls. In contrast, no significant differences in severity of glomerulonephritis were observed between groups. Vasculitis was also observed in other organs of eNOS‐deficient mice, including in the lungs of several of these animals. Ultrastructural analyses of renal lesions revealed the presence of electron‐dense deposits in affected arteries, and IgG, IgA, and C3 deposition was observed in some vessels in the kidneys of Nos3 −/− mice. In addition, Nos3 −/− MRL/MpJ‐ Fas lp mice showed increased levels of circulating IgG–IgA immune complexes at 20 weeks of age, compared to Nos3 +/+ MRL/MpJ‐ Fas lpr and Nos3 −/− C57BL/6 mice. Conclusion These findings strongly indicate that eNOS serves as a negative regulator of vasculitis in MRL/MpJ‐ Fas lpr mice and further suggest that NO produced by this enzyme may be critical for inhibiting lesion formation and vascular damage in human vasculitic diseases.